Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
July 13, 2009
- 2009 IP Promotion Plan Calls For Patent Protection for New Dosage and Treatment Regimens
July 13, 2009
- Bayer Moves Oncology Business Unit to Tokyo
July 6, 2009
- IP Injection of Paclitaxel Approved
July 6, 2009
- Blopress Keeps Top Place 5 Years in a Row
July 6, 2009
- New GL on COPD to Recommend β2 Stimulant + Inhaled Steroid Combinations
July 6, 2009
- FY2008 Sales of Ethical Drugs Up 2.9% to ¥8,368.6 Bil.: IMS Japan
July 6, 2009
- JSMI Introduces New Voluntary GL for Ad of OTC Drugs
July 6, 2009
- BUSINESS NEWS IN BRIEF
July 6, 2009
- Alogliptin Approval to Be Delayed at Least 2 Years: Takeda
July 6, 2009
- REGULATORY NEWS IN BRIEF
July 6, 2009
- Sandoz's Growth Hormone Approved as Japan's First Biosimilar
July 6, 2009
- JSGM Proposes Free Pricing System for Generics
July 6, 2009
- Korosho Asks MEXT to Cooperate to Increase Use of Generics by National Univ. Hospitals
July 6, 2009
- J&J to Launch Cor-Tyzine for Nasal Allergy
July 6, 2009
- Kyowa Kirin Initiates PII Trial for KW-0761 in Japan
July 6, 2009
- R&D NEWS IN BRIEF
July 6, 2009
- Korosho's Council Recommends Early Development of Plerixafor
July 6, 2009
- NEW PRODUCTS
July 6, 2009
- JSA Proposes Outline of Law on Measures against Stroke
July 6, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…